Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study

OBJECTIVE: To evaluate the performance of clinical criteria for predicting late treatment failure in patients with early non-response to certolizumab pegol (CZP). METHODS: A protocol-specified analysis of interim data from ECLAIR, a 3-year longitudinal, prospective, observational, multicentre study...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraux, Alain, Flipo, René-Marc, Fagnani, Francis, Massol, Jacques, Cukierman, Gabrielle, Joubert, Jean-Michel, Huot-Marchand, Philippe, Combe, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046983/
https://www.ncbi.nlm.nih.gov/pubmed/31958276
http://dx.doi.org/10.1136/rmdopen-2019-000991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046983/
https://www.ncbi.nlm.nih.gov/pubmed/31958276
http://dx.doi.org/10.1136/rmdopen-2019-000991

Ejemplares similares